http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Ga-Ram You,Seon-Young Park,Hye-Su You,Seung-Young Seo,Sung-Kyun Yim,Byung-Chul Jin,Jung-In Lee,Young-Dae Kim,Suck-Chei Choi,Chan-Guk Park,Wan-Sik Lee 대한상부위장관ㆍ헬리코박터학회 2023 Korean Journal of Helicobacter Upper Gastrointesti Vol.23 No.4
Objectives: Gastrointestinal cytomegalovirus (CMV) disease is a major contributor to mortality in immunocompromised patients. Few studies have discussed upper gastrointestinal CMV (UGICMV) disease in immunocompetent patients. We compared the clinical outcomes of UGI-CMV between immunocompromised and immunocompetent patients.Methods: This retrospective study included patients with UGI-CMV disease from five tertiary hospitals across Korea (2010– 2022). Patients’ clinical data and outcomes were recorded.Results: UGI-CMV was diagnosed in 54 patients; 27 (50.0%) had esophageal, 24 (44.4%) had gastric, and 3 patients (5.6%) had duodenal involvement. Patients’ median age was 64 years (interquartile range 53–75 years), and the most common comorbidities included hypertension (57.4%) and diabetes (38.9%). The predominant symptom was abdominal pain (46.3%), and the most common endoscopic finding was ulcers (70.4%). Antiviral treatment was administered to 31 patients, and 23 patients underwent observation without treatment. We investigated 32 immunocompromised (59.3%) and 22 immunocompetent (40.7%) patients and observed no intergroup differences in comorbidities and in laboratory and endoscopic findings. Immunocompromised patients had longer length of hospitalization (median 46.2 days vs. 20.0 days, <i>p</i>=0.001). However, treatment outcomes, including the need for intensive care unit admission and mortality did not significantly differ. The overall mortality rate was 13.0%; one patient from the immunocompromised group died of UGI-CMV disease. The treatment success rate was higher in immunocompromised patients who received antiviral therapy (<i>p</i>=0.011).Conclusions: UGI-CMV disease is not uncommon in immunocompetent patients, although symptoms are milder than those in immunocompromised patients. Our findings emphasize the importance of clinical vigilance for accurate diagnosis of CMV infection, particularly in susceptible symptomatic patients and highlight the need for active antiviral treatment for management of immunocompromised patients.
Ga Ram Kim,You Jin Ku,Soon Gu Cho,Sei Joong Kim,Byung Soh Min 대한외과학회 2017 Annals of Surgical Treatment and Research(ASRT) Vol.93 No.1
Purpose: To evaluate whether the Breast Imaging Reporting and Data System (BI-RADS) MRI lexicon could reflect the genomic information of breast cancers and to suggest intuitive imaging features as biomarkers. Methods: Matched breast MRI data from The Cancer Imaging Archive and gene expression profile from The Cancer Genome Atlas of 70 invasive breast cancers were analyzed. Magnetic resonance images were reviewed according to the BIRADS MRI lexicon of mass morphology. The cancers were divided into 2 groups of gene clustering by gene set enrichment analysis. Clinicopathologic and imaging characteristics were compared between the 2 groups. Results: The luminal subtype was predominant in the group 1 gene set and the triple-negative subtype was predominant in the group 2 gene set (55 of 56, 98.2% vs. 9 of 14, 64.3%). Internal enhancement descriptors were different between the 2 groups; heterogeneity was most frequent in group 1 (27 of 56, 48.2%) and rim enhancement was dominant in group 2 (10 of 14, 71.4%). In group 1, the gene sets related to mammary gland development were overexpressed whereas the gene sets related to mitotic cell division were overexpressed in group 2. Conclusion: We identified intuitive imaging features of breast MRI associated with distinct gene expression profiles using the standard imaging variables of BI-RADS. The internal enhancement pattern on MRI might reflect specific gene expression profiles of breast cancers, which can be recognized by visual distinction.
Lee, Seul Ah,You, Ga Rim,Choi, Ye Won,Jo, Hyun Yong,Kim, Ah Ram,Noh, Insup,Kim, Sung-Jin,Kim, Youngmee,Kim, Cheal The Royal Society of Chemistry 2014 Dalton Transactions Vol.43 No.18
<P>A multifunctional fluorescent and colorimetric receptor <B>1</B> ((<I>E</I>)-<I>N</I>′-((8-hydroxy-1,2,3,5,6,7-hexahydropyrido[3,2,1-<I>ij</I>]quinolin-9-yl)methylene)benzohydrazide) for the detection of both Al<SUP>3+</SUP> and CN<SUP>−</SUP> in aqueous solution has been developed. Receptor <B>1</B> exhibited an excellent selective fluorescence response toward Al<SUP>3+</SUP>. The sensitivity of the fluorescent based assay (0.193 μM) for Al<SUP>3+</SUP> is far below the limit in the World Health Organization (WHO) guidelines for drinking water (7.41 μM). In addition, receptor <B>1</B> showed an excellent detection ability in a wide pH range of 4–10 and also in living cells. Moreover, receptor <B>1</B> showed a highly selective colorimetric response to CN<SUP>−</SUP> by changing its color from colorless to yellow immediately without any interference from other anions.</P> <P>Graphic Abstract</P><P>A new multifunctional Schiff-base receptor <B>1</B> which exhibits an excellent cell-permeable fluorescence for Al<SUP>3+</SUP> and a color change for CN<SUP>−</SUP> in aqueous media has been prepared. <IMG SRC='http://pubs.rsc.org/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=c4dt00361f'> </P>